In a second similar study, the separation and isolation of specific cell populations were used to increase the sensitivity of BCR::ABL1 molecular analysis [62] in order to evaluate the lineage of residual CML cells in TFR [63••]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.